NS21: re-defined and modified supplement B27 for neuronal cultures
- PMID: 18471889
- PMCID: PMC2678682
- DOI: 10.1016/j.jneumeth.2008.03.013
NS21: re-defined and modified supplement B27 for neuronal cultures
Abstract
In vitro culturing of primary neurons is a mainstay of neurobiological research. Many of these culture paradigms have taken advantage of defined culture media rather than serum additives that contain undefined survival factors to facilitate experimental manipulations and interpretation of the results. To culture neurons in the absence of serum, defined supplements such as B27 are now widely used. However, commercially available supplements exhibit large variability in their capabilities to support neurons in culture. We re-optimized and modified earlier published formulations of B27 using 21 different ingredients (NS21). NS21 supports neuronal cultures of high quality as manifested by their morphological characteristics, formation of synapses, and postsynaptic responses. Much of the variability in the quality of B27/NS21 was due to variability in the quality of different sources of bovine serum albumin. Furthermore, we found that holo-transferrin used in NS21 is preferable over apo-transferrin used in B27 for the quality of neuronal cultures.
Figures
References
-
- Araki T, Sasaki Y, Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science. 2004;305:1010–3. - PubMed
-
- Barres BA, Silverstein BE, Corey DP, Chun LL. Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron. 1988;1:791–803. - PubMed
-
- Brewer GJ, Cotman CW. Survival and growth of hippocampal neurons in defined medium at low density: advantages of a sandwich culture technique or low oxygen. Brain Res. 1989;494:65–74. - PubMed
-
- Brewer GJ, Torricelli JR, Evege EK, Price PJ. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res. 1993;35:567–76. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R56 AG017502/AG/NIA NIH HHS/United States
- NS035563/NS/NINDS NIH HHS/United States
- R01 NS046450/NS/NINDS NIH HHS/United States
- DA15043/DA/NIDA NIH HHS/United States
- R01 DA015043/DA/NIDA NIH HHS/United States
- AG017502/AG/NIA NIH HHS/United States
- R01 AG017502/AG/NIA NIH HHS/United States
- R56 AG013730/AG/NIA NIH HHS/United States
- AG013730/AG/NIA NIH HHS/United States
- NS039358/NS/NINDS NIH HHS/United States
- RF1 AG013730/AG/NIA NIH HHS/United States
- R01 AG013730/AG/NIA NIH HHS/United States
- R01 NS035563/NS/NINDS NIH HHS/United States
- R01 NS039358/NS/NINDS NIH HHS/United States
- NS046450/NS/NINDS NIH HHS/United States
- R37 DA015043/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
